Table 1 Demographic and intraoperative data
Control group | ESPB group | p value | |
|---|---|---|---|
Sample size, n | 108 | 105 | |
Age (years; mean (SD)) | 66.7 (5.5) | 65.7 (4.4) | 0.17 |
Sex (n (% men) | 53 (49.1) | 44 (41.9) | 0.29 |
BMI (kg/m2; mean (SD)) | 24.8 (3.2) | 24.7 (2.6) | 0.71 |
Hypertension (n (%)) | 40(37.0) | 35(33.3) | 0.57 |
Diabetes (n (%)) | 37(34.3) | 32(30.5) | 0.56 |
ASA status (n (%)) | 0.49 | ||
I | 27(25.0) | 34(32.4) | |
II | 56(51.9) | 50(47.6) | |
III | 25(23.1) | 21(20.0) | |
MMSE (mean (SD)) | 26.7 (2.0) | 26.6 (2.0) | 0.78 |
Operative segments (n (%)) | 0.87 | ||
1 | 34(31.5) | 38(36.2) | |
2 | 52(48.1) | 49(46.6) | |
3 | 19(17.6) | 15(14.3) | |
4 | 3(2.8) | 3(2.9) | |
Operative duration (min; mean (SD)) | 152.0 (54.5) | 142.7 (45.6) | 0.18 |
Total blood loss (mL; median (IQR)) | 225(100–400) | 200 (100–300) | 0.13 |
Ephedrine (mg; median (IQR)) | 18(10–24) | 18(6–24) | 0.74 |
Phenylephrine (µg; median (IQR)) | 100(0-857) | 60(0-457) | 0.47 |
Remifentanil [µg/(kg·h); mean (SD)] | 10.01 (1.23) | 6.67 (1.18) | < 0.001 |